Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-05-03
2005-05-03
Tsang, Cecilia J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S878000, C560S075000, C568S315000, C568S325000
Reexamination Certificate
active
06887898
ABSTRACT:
The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the invention relates to the use of natural product compounds isolated from turmeric, gingko biloba, and ginger, and synthetic chemical analogues thereof, for the treatment of a beta-Amyloid protein-induced disease.
REFERENCES:
patent: 5266344 (1993-11-01), Mimura et al.
patent: 07206669 (1995-08-01), None
patent: 11246398 (1999-09-01), None
patent: WO 9703674 (1997-02-01), None
patent: WO 9851302 (1998-11-01), None
patent: WO 0070949 (2000-11-01), None
Artico et al., “Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase: Synthesis, Biological Evaluation, and Molecular Modeling,”J. Med. Chem., 41:3948-3960 (1998).
Chang et al., “The effect of Chinese medicinal herbZingiberis rhizomaextract on cytokine secretion by human peripheral blood mononuclear cells,”J. Ethnopharmacology, 48:13-19 (1995).
Clostre, “Ginkgo bilobaextract (EGb 761): A state of art at the dawn of the third millennium,”Annales Pharmaceutiques Francaises, 57, No. Suppl. 1:1S8-1S88 (1999).
Conney et al., “Inhibitory Effect of Curcumin and Some Related Dietary Compounds on Tumor Promotion and Arachidonic Acid Metabolism in Mouse Skin,”Advances in Enzyme Regulation,Proceedings of the Thirty-First Symposium on Regulation of Enzyme Activity and Synthesis in Normal and Neoplastic Tissues held in Indiana University School of Medicine, Weber, ed., vol. 31, pp. 385-396 (1991).
Gellerman et al., “Antimicrobial Effects of Anacardic Acids,”Canadian Journal of Microbiology, 15:1219-1223 (1969).
He et al., “High-performance liquid chromatography-electrospray mass spectrometric analysis of pungent constituents of ginger,”J. Chromatography A, 796:327-334 (1998).
Hiserodt et al., “Isolation of 6-, 8-, and 10-Gingerol from Ginger Rhizome by HPLC and Preliminary Evaluation of Inhibition ofMycobacterium aviumandMycobacterium tuberculosis,” J. Agric. Food Chem., 46:2504-2508 (1998).
Huang et al., “Novel Bipheny Ether Liganans from the Rhizomes ofCurcuma chuanyujin,” Chem. Pharm. Bull, 48(8):1228-1229 (2000).
Itokawa et al., “Antitumor Principles fromGinkgo bilobaL.,”Chem. Pharm. Bull., 35(7):3016-3020 (1987).
Jung et al., “Effects of Curcumin on the Microglial Activation,”Yakhak Hoeji, 44(5):448-454 (2000).
Kelloff et al., “Chemopreventive Drug Development: Perspectives and Progress,”Cancer Epidemiol. Biomarkers&Prev., 3:85-98 (1994).
Khopde et al., “Free radical scavenging ability and antioxidant efficiency of curcumin and its substituted analogue,”Biophysical Chemistry, 80:85-91 (1999).
Kim et al., “Inhibition of β-Amyloid Neurotoxicity in PC12 Cells by CLZ-1, CLZ-2 and CLZ-3 Isolated fromCurcuma Longa, Zingiberaceae:An Approach Toward A Rational Drug Discovery Of Anti-Alzheimer Disease,”Society For Neuroscience Abstracts, 24(1-2):1457 (1998).
Kim et al., “Curcuminoids fromCurcuma longaL. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA(1-42) insult,”Neuroscience Letters, 303:57-61 (2001).
Kuner et al., “β-Amyloid Binds to p75NTRand Activates NFκB in Human Neuroblastoma Cells,”J. Neuroscience Res., 54:798-804 (1998).
Lee et al., “Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol,”Cancer Letters, 134:163-168 (1998).
Lim et al., “Prevention of LTP deficits in Alzheimer transgenic HuAPPSw mice using a phenolic anti-oxidant/anti-inflammatory compound,”Society for Neuroscience Abstracts, 26(1-2):Abstract No. 763.9 (2000).
Maurer et al., “Clinical Efficacy ofGinkgo BilobaSpecial Extract EGb 761 in Dementia of the Alzheimer Type,”J. psychiat. Res., 31(6):645-655 (1997).
Morimoto et al., “Sterische Struktur der Giftstoffe aus dem Fruchtfleisch onGinkgo bilobaL.”,Chem. Pharm. Bull., 16(11):2282-2286 (1968).
Nagabhushan et al., “Mutagenicity Of Gingerol And Shogaol And Antimutagenicity Of Zingerone in Salmonella/Microsome Assay,”Cancer Letters, 36:221-233 (1987).
Nakayama, “Strategy of Chemical Modification to Free Radical Scavengers for Suppression of Hydrogen Peroxide-Induced Cytotoxicity,”Food Factors Cancer Prev., Int. Conf., 1995,pp. 642-646 (1997).
Niijima et al., “Effect of oral administration ofPinellia ternata, Zingiberis rhizomaand their mixture on the efferent activity of the gastric branch of the vagus nerve in the rat,”Neuroscience Letters, 258:5-8 (1998).
Nurfina et al., “Synthesis of some symmetrical curcumin derivatives and their anti-inflammatory activity,”Eur. J. Med. Chem., 32:321-328 (1997).
Osawa et al., “Antioxidative Activity of Tetrahydrocurcuminoids,”Biosci. Biotech. Biochem., 59(9):1609-1612 (1995).
Prasain et al., “Inhibitory Effect of Diarylheptanoids on Nitric Oxide Production in Activated Murine Macrophages,”Biol. Pharm. Bull., 21(4):371-374 (1998).
Ruby et al., “Anti-tumour and antioxidant activity of natural curcuminoids,”Cancer Letters, 94: 79-83 (1995).
Schulick,Ginger, Common Spice&Wonder Drug,3rdedition, Hohm Press, pp. 1-166 (1996).
Skolnick, “Old Chinese Herbal Medicine Used for Fever Yields Possible New Alzheimer Disease Therapy,”JAMA, 277(10):776 (1997).
Soliman et al., “In vitro Attenuation of Nitric Oxide Production in C6 Astrocyte Cell Culture by Various Dietary Compounds,”Proc. Soc. Exper. Biol. Med., 218(4):390-397 (1998).
Suekawa et al., “Pharmacological Studies On Ginger. I. Pharmacological Actions Of Pungent Constituents, (6)-Gingerol and (6)-Shogaol,”J. Pharm. Dyn.,7:836-848 (1984).
Venkateshwarlu, “Cyclo-Oxygenase Inhibitors From Spices,”Indian Drugs, 34(8):427-432 (1997).
Yoshikawa et al., “Qualitative and Quantitative Analysis of Bioactive Principles in Zingiberis Rhizoma by Means of High Performance Liquid Chromatography and Gas Liquid Chromatography. On the Evaluation of Zingiberis Rhizoma and Chemical Change of Constituents during Zingiberis Rhizoma Processing,” Regular Articles,Yakugaku Zasshi, 113:307-315 (1993).
International Search Report dated Mar. 8, 2002 for International Application No. PCT/US00/41436.
Written Opinion dated Mar. 18, 2002 for International Application No. PCT/US00/41436.
Marshall & Gerstein & Borun LLP
Oh Taylor V.
Tsang Cecilia J.
LandOfFree
Pharmaceutical compositions useful in prevention and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions useful in prevention and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions useful in prevention and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3456732